George Regional Health System | |
859 Winter Street, Lucedale, Mississippi 39452 | |
(601) 947-3161 | |
Name | George Regional Health System |
---|---|
Type | Acute Care Hospital |
Location | 859 Winter Street, Lucedale, Mississippi |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 250036 |
NPI Number | 1023074028 |
Organization Name | GEORGE COUNTY HOSPITAL |
Address | 859 Winter St, Lucedale, MS 39452 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 601-947-3161 |
News Archive
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Mount Sinai surgeons have performed the first-ever spinal tethering surgery in New York City to correct idiopathic scoliosis-;a sideways curvature in the spine-;in children and adolescents.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 9 days ago
NPI Number | 1093752602 |
Organization Name | GEORGE COUNTY HOSPITAL- ERP |
Address | 859 Winter St, Lucedale, MS 39452 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 601-947-9148 |
News Archive
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Mount Sinai surgeons have performed the first-ever spinal tethering surgery in New York City to correct idiopathic scoliosis-;a sideways curvature in the spine-;in children and adolescents.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 9 days ago
NPI Number | 1477590099 |
Organization Name | GEORGE COUNTY HOSPITAL |
Address | 859 Winter St, Lucedale, MS 39452 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 601-947-3161 |
News Archive
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Mount Sinai surgeons have performed the first-ever spinal tethering surgery in New York City to correct idiopathic scoliosis-;a sideways curvature in the spine-;in children and adolescents.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 9 days ago
NPI Number | 1750648515 |
Organization Name | GEORGE REGIONAL HOSPITAL |
Address | 859 Winter St, Lucedale, MS 39452 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-947-3161 |
News Archive
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Mount Sinai surgeons have performed the first-ever spinal tethering surgery in New York City to correct idiopathic scoliosis-;a sideways curvature in the spine-;in children and adolescents.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 9 days ago
NPI Number | 1982641593 |
Organization Name | GEORGE COUNTY HOSPITAL- CRNA |
Address | 859 Winter St, Lucedale, MS 39452 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 601-947-3161 |
News Archive
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Mount Sinai surgeons have performed the first-ever spinal tethering surgery in New York City to correct idiopathic scoliosis-;a sideways curvature in the spine-;in children and adolescents.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 9 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Mount Sinai surgeons have performed the first-ever spinal tethering surgery in New York City to correct idiopathic scoliosis-;a sideways curvature in the spine-;in children and adolescents.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 9 days ago
George Regional Health System Acute Care Hospital Location: 859 Winter Street, Lucedale, Mississippi 39452 Phone: (601) 947-3161 |